view article
Figure 3
(a) Scheme of the glass flow-through capillary. (b) Diffraction patterns of ibrutinib polymorph C and of the prepared ibrutinib solvates. (c) Time series of diffraction patterns observed during the transformation of ibrutinib C to the FBZ solvate.

IUCrJ
Volume 10| Part 2| March 2023| Pages 210-219
ISSN: 2052-2525
https://doi.org/10.1107/S2052252523001197